AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 171 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,474,000 | +270.4% | 192,052 | +336.5% | 0.19% | +263.5% |
| Q4 2018 | $668,000 | +25.6% | 44,000 | +65.3% | 0.05% | +36.8% |
| Q3 2018 | $532,000 | -72.5% | 26,624 | -73.2% | 0.04% | -72.9% |
| Q2 2018 | $1,935,000 | -22.4% | 99,222 | -19.8% | 0.14% | -25.5% |
| Q1 2018 | $2,494,000 | -42.7% | 123,787 | -62.3% | 0.19% | -41.2% |
| Q4 2017 | $4,352,000 | -63.7% | 328,455 | -4.5% | 0.32% | -61.3% |
| Q4 2016 | $11,974,000 | +351.7% | 344,103 | +215.1% | 0.83% | +268.8% |
| Q4 2013 | $2,651,000 | +70.0% | 109,205 | +50.4% | 0.22% | +41.8% |
| Q3 2013 | $1,559,000 | -55.1% | 72,629 | -53.5% | 0.16% | -62.7% |
| Q2 2013 | $3,473,000 | – | 156,129 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |